11th Mar 2021 21:33
BATM Advanced Communications Ltd - provides technologies for networking solutions and medical laboratory systems - Says it has launched a new molecular diagnostics kit that uses self-collected saliva samples to test for SARS-CoV-2. "This significantly improves the sample collection process compared with existing swabbing methods while, as an RT-PCR test, maintaining diagnostic accuracy," BATM explains, adding it has started taking orders and expects to begin delivering the kit in April.
Current stock price: 105.50 pence
Year-to-date change: up 9.1%
By Arvind Bhunjun; [email protected]
Copyright 2021 Alliance News Limited. All Rights Reserved.
Related Shares:
Batm Advanced